Zalicus Company
Zalicus discovers and develops novel-target pain therapies, including calcium channel modulator for chronic and acute inflammatory pain.
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2000
Employees Number:
11-50
Funding Status:
M&A
Register and Claim Ownership